Refresh

ANG Lifesciences India Ltd - Announcement under Regulation 30 (LODR)-Acquisition


Download
24 Nov 2021
Pursuant to Regulation 30 of SEBI (Listing Obligation & Disclosure Requirements), 2015, we would like to inform you that the Company's Board of Directors in their meeting held on 23-Nov-2021, has decided to invest in the equity shares of ANG Healthcare India Private Limited. Therefore consequent to the acquisition of 100% Equity stake by the company, ANG Healthcare India Private Limited will become Wholly-Owned Subsidiary Company of ANG Lifesciences India Limited.<BR> <BR> ANG Healthcare India Private Limited is a marketing company selling critical care products to Hospitals and Nursing Homes in therapeutic segments of anti-biotic, anti-infective, anti-malarial, pain management etc. The company has got presence all over India through a network of Super Stockists and 150 Stockists along with a strong sales force of about 60 personnel and expanding at a fast pace. <BR> <BR>

Source: BSE India

View all announcements for ANG Lifesciences India Ltd
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com